#TakeAction – June 13, 2019
Let’s #TakeAction to bring down drug prices; health care is a human right!
🔶 Ask Rep. Schrier to Cosponsor the Medicare Negotiation and Competitive Licensing Act
1. (ACTION) Call Congresswoman Schrier, urge her to cosponsor H.R. 1046:
This bill lifts the restrictions that currently prevent Medicare from negotiating with drug companies, but just as importantly it would give Medicare the leverage it needs to negotiate effectively without putting patients at risk. Here’s how it would work:
• Under H.R. 1046, the Secretary of Health and Human Services would be required to negotiate prices for covered Medicare Part D drugs (which is most drugs). This would help to bring down spending on prescription drugs by billions of dollars, since Medicare Part D has a tremendous amount of purchasing power.
• If the negotiations don’t arrive at an appropriate price, the Secretary would be required to issue a “competitive license.” A competitive license means generic producers of drugs would be allowed to manufacture competitors to name brand drugs when the drug company that owns the patent refuses to responsibly negotiate with Medicare. This competition would subsequently bring down the price of the drug for patients.
• This approach would put drug companies’ monopolies in the crosshairs—not a patient’s access to medicine. Whether companies are willing to negotiate their prices down or must deal with generic competition, patients will come out paying lower prices.
• Indivisible: https://indivisible.org/…/hr-1046-act-now-bring-drug-prices…
• Commonwealth Fund: https://www.commonwealthfund.org/…/paying-prescription-drug…
• If Medicare were able to purchase medications at the same prices the Veteran’s Administration pays, the US government would save billions of dollars: https://jamanetwork.com/…/jamainte…/article-abstract/2720124
• Taxpayer funding for drug development: https://www.pnas.org/content/115/10/2329